Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
BIEI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

premier biomedical inc (BIEI) Snapshot

Open
$0.05
Previous Close
$0.05
Day High
$0.05
Day Low
$0.05
52 Week High
10/29/14 - $0.33
52 Week Low
07/24/15 - $0.05
Market Cap
1.1M
Average Volume 10 Days
16.8K
EPS TTM
--
Shares Outstanding
21.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PREMIER BIOMEDICAL INC (BIEI)

Related News

No related news articles were found.

premier biomedical inc (BIEI) Related Businessweek News

No Related Businessweek News Found

premier biomedical inc (BIEI) Details

Premier Biomedical, Inc., a research-based company, discovers and develops medical treatments for various health issues. The company develops Sequential-Dialysis Technique, a methodology for the removal of molecules that are harmful and responsible for causing diseases, such as cancer, muscular dystrophy, neurofibromatosis, Ebola, etc., as well as to prevent the onset of various diseases; and Feldetrex drug candidate for the treatment of fibromyalgia and neuropathy. The company intends to market its products to pharmaceutical and/or medical devices firms. Premier Biomedical, Inc. has a collaborative agreement with the University of Texas to develop a series of research and development programs for its sequential-dialysis technology in the areas of cancer, chronic pain syndrome, fibromyalgia, multiple sclerosis, amyotrophic lateral sclerosis, blood sepsis, heart attacks, and strokes. The company was founded in 2010 and is based in El Paso, Texas.

premier biomedical inc (BIEI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

premier biomedical inc (BIEI) Key Developments

Premier Biomedical Announces the Addition of Dr. Ryan C. Fields to Scientific Advisory Board

Premier Biomedical, Inc. announced the addition of Dr. Ryan C. Fields to their Scientific Advisory Board effective immediately. Dr. Fields will report to the Chairman of the Scientific Advisory Board and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman. Ryan C. Fields, M.D., F.A.C.S. is an Assistant Professor of Surgical Oncology at Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine in St. Louis, Missouri. He also serves as an Associate Program Director for the General Surgery Residency Program and is Director of Resident Research.

Premier Biomedical, Inc. announced delayed 10-Q filing

On 11/14/2014, Premier Biomedical, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Premier Biomedical, Inc. Adds Patricio F. Reyes to Scientific Advisory Board

Premier Biomedical, Inc. announced the addition of Dr. Patricio F. Reyes to their Scientific Advisory Board effective immediately. Dr. Reyes will report to the Chairman of the Scientific Advisory Board and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman. Dr. Reyes is a board member, and former Chair of the Education Committee. Dr. Reyes is a co-founder, Chief Medical Officer and Chair of the Scientific Advisory Board of Yuma Therapeutics, Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIEI:US $0.05 USD 0.00

BIEI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIEI.
View Industry Companies
 

Industry Analysis

BIEI

Industry Average

Valuation BIEI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PREMIER BIOMEDICAL INC, please visit www.premierbiomedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.